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Abstract
Bacterial exopolysaccharides have always been suggested to play crucial roles in the bacterial initial adhesion and the
development of complex architecture in the later stages of bacterial biofilm formation. However, Escherichia coli group II
capsular polysaccharide was characterized to exert broad-spectrum biofilm inhibition activity. In this study, we firstly
reported that a bacterial exopolysaccharide (A101) not only inhibits biofilm formation of many bacteria but also disrupts
established biofilm of some strains. A101 with an average molecular weight of up to 546 KDa, was isolated and purified
from the culture supernatant of the marine bacterium Vibrio sp. QY101 by ethanol precipitation, iron-exchange
chromatography and gel filtration chromatography. High performance liquid chromatography traces of the hydrolyzed
polysaccharides showed that A101 is primarily consisted of galacturonic acid, glucuronic acid, rhamnose and glucosamine.
A101 was demonstrated to inhibit biofilm formation by a wide range of Gram-negative and Gram-positive bacteria without
antibacterial activity. Furthermore, A101 displayed a significant disruption on the established biofilm produced by
Pseudomonas aeruginosa, but not by Staphylococcus aureus. Importantly, A101 increased the aminoglycosides antibiotics’
capability of killing P. aeruginosa biofilm. Cell primary attachment to surfaces and intercellular aggregates assays suggested
that A101 inhibited cell aggregates of both P. aeruginosa and S. aureus, while the cell-surface interactions inhibition only
occurred in S. aureus, and the pre-formed cell aggregates dispersion induced by A101 only occurred in P. aeruginosa. Taken
together, these data identify the antibiofilm activity of A101, which may make it potential in the design of new therapeutic
strategies for bacterial biofilm-associated infections and limiting biofilm formation on medical indwelling devices. The found
of A101 antibiofilm activity may also promote a new recognition about the functions of bacterial exopolysaccharides.
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Introduction
Bacterial biofilms are dense aggregates of cell–cell or surface-
attached microorganisms encased in a hydrated extracellular
polymeric substances matrix of self synthesized [1,2]. Bacterial
pathogens living in biofilm induce persistent chronic infections due
to the resistance to antibiotics and host immune system as a result
of the diffusion barrier, metabolism slowly, genetic mutant, biofilm
specific phenotypes, persistent cells and so on [3,4]. Compared
with the planktonic ones, bacteria within the biofilm state are
upward of 1000-times more resistant to conventional antibiotic
treatment and host immune responses [5,6]. Recent estimates
suggest that bacterial biofilms are accounting for over 80% of
microbial infections in the body [3,7]. Therefore, searching for
compounds or strategies to decrease bacterial biofilm formation or
the antibiotics resistance of the pathogens in biofilms, is very
essential and useful for the treatment of biofilm-associated disease.
The traditional approach to prevent biofilm formation in vivo is
local administration of biocides [8]. However, the bacterial
biofilms often persist in the presence of large doses of traditional
antimicrobial agents [9]. Recently various approaches were
proposed and expected to be effective in directly preventing or
eliminating bacterial biofilms. One of common effective strategies
is directly targeting at the component of biofilm. For example, the
enzymes to degrade extracellular matrix or exopolysaccharide
(EPS) were shown not only to inhibit biofilm formation, but also to
remove pre-existing biofilms effectively, although the effects
depend on the specificity of EPS matrix composition of biofilms
[10–13].
EPS is a common component of biofilm and its production is an
important feature of the mature biofilm [5]. In many bacteria,
increased biofilm formation often correlates with increased EPS
production. During the process of biofilm formation, by using EPS
glycocalyx polymers, bacterial cells initiate the adhesion to the
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addition, EPSs form the matrix that embeds the bacteria, where
additional free bacteria can be entrapped [18,19]. However, few
bacterial EPSs were recently found to negatively regulate biofilm
formation. Capsular polysaccharide (CPS) transportation protein
gene mutant in Vibrio vulnificus [20] or a putative glycosyltransfer-
ase gene deletion in Porphyromonas gingivalis [21] was found to
decrease the production of EPSs and enhance biofilm formation of
themselves. Jaione Valle el. at reported that E. coli group II
capsular polysaccharide exerted broad-spectrum biofilm inhibition
activity; however, it had no effect on the established biofilms [22].
In addition, P. aeruginosa extracellular products, mainly polysac-
charides, were found to disrupt the established S. epidermidis and S.
aureus biofilms [23], but biofilms of other pathogens are not
involved.
In this study, we showed that an exopolysaccharide A101
purified from culture supernatant of the marine bacterium Vibrio
sp. QY101 not only inhibited biofilm formation by a wide range of
Gram-negative and Gram-positive bacteria, but also disrupted the
established biofilms of some strains. Furthermore, A101-mediated
biofilm disruption significantly decreased the minimum biofilm
eradication concentration (MBEC) of antibiotics. And the
mechanism underlying the antibiofilm effect of A101 was
preliminarily investigated. This is the first reported bacterial EPS
that exhibits both biofilm formation inhibition activity and pre-
existing biofilm disruption activity.
Results
Vibrio sp. QY101 culture supernatant inhibits biofilm
formation of P. aeruginosa FRD1
The alginate lyase-producing marine bacterium Vibrio sp.
QY101 was isolated from a decaying thallus of Laminaria [24].
Here its culture supernatant was discovered to inhibit P. aeruginosa
FRD1 biofilm formation, which was not caused by the original
medium (Figure 1A). It has been reported that the acetylated
alginate was very important for P. aeruginosa FRD1 biofilm
formation [25]. Therefore, we speculated that the biofilm
inhibitory activity of the culture supernatant was due to the
alginate lyase activity. However, it was found that the purified
alginate lyase from Vibiro sp. QY101 had no biofilm inhibitory
activity (data not shown), and the culture supernatant still inhibited
P. aeruginosa FRD1 biofilm formation after loss of enzyme activity
(Figure 1B), demonstrating the active factor was not alginate lyase.
To elucidate the active component, ethanol precipitation,
dialysis and freeze-dried were applied to extract the active factor
from the supernatant of Vibrio sp. QY101. Then proteinase K,
nuclease and NaIO4, were used to digest the crude extract (crude-
A101), respectively. As shown in Figure 2A and 2B, pretreatment
crude-A101 with proteinase K and nuclease had no effect on the
antibiofilm activity, while pretreatment with NaIO4 resulted in a
more than 60% decrease (Figure 2C). It is well known that NaIO4
is able to hydrolyze polysaccharides by oxidizing the carbons
bearing vicinal hydroxyl groups and cleaving the C-C bonds
[15,26]. These data suggested that the biologically active
component was likely a polysaccharide.
Isolation and purification of the active polysaccharide
The crude polysaccharides were extracted from the supernatant
of QY101 and then were further purified by DEAE Sepharose
Fast Flow column. The fraction eluted by 0.5 mol/L NaCl
contained abundant active sugars (Figure S1A). The active fraction
was pooled, dialyzed, lyophilized and was further fractionated on a
Sephacryl S-400 HR column eluting with 0.2 mol/L ammonium
bicarbonate (Figure S1B). Finally, one active polysaccharide was
obtained and named as A101.
IR spectra and chemical compositions of A101
Fourier transform infrared spectra (FT-IR) of A101 revealed
typical characteristics of polysaccharides, which displayed a
stretching vibration at 3417 cm
21 for the hydroxyl group and a
weak C–H stretching band at 2925 cm
21. The characteristic
absorption at 1634 cm
21 was also observed, suggesting the
presence of C-O bonds, whose symmetrical stretching vibration
was at 1416 cm
21. The signals at 1040–1082 cm
21 were
attributed to the stretch vibration of C–O and change angle
vibration of O–H.
High performance liquid chromatography (HPLC) traces of
the polysaccharide hydrolyzates showed monosaccharide com-
ponents of A101. As shown in Table S1, the predominant
monosaccharides of A101 were glucuronic acid (21.47%),
galacturonic acid (23.05%), rhamnose (23.90%) and glucosamine
(12.15%). Besides the four abundant monosaccharides, mannose,
glucose, galactose and fucose were also present in A101 at low
level. Additional, high performance gel permeation chromatog-
raphy (HPGPC) was applied to elucidate the molecular weight
(Mw) of the polysaccharide. One independent and symmetrical
peak was identified and the average Mw value of A101 is about
546 KDa.
Figure 1. Effect of Vibrio sp. QY101 supernatant on biofilm
formation of P. aeruginosa FRD1. Vibrio sp. QY101 was grown in AM
at 25uC for 4 days. Its supernatant was taken to examine the effect on
bacterial biofilm formation. P. aeruginosa FRD1 biofilm formed in micro-
tubes at 37uC for 24 h. Attached biofilm biomass was determined by
measuring crystal violet retained at OD590 nm. Results are the average
of six replicates 6 SD at least three independent experiments. (A) 1/10
(v/v) supernatant was added in the cultures. (P,0.01). Control: sterile
water; Medium: alginate medium; FS: fermentation supernatant. (B) The
supernatant was treated to make the alginate lyase inactive before
being added in the cultures. Alginate lyase activity was measured by an
increase in absorbance at 235 nm of the reaction products.
doi:10.1371/journal.pone.0018514.g001
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not result from reducing bacterial growth
In the microtiter plates biofilm assays, A101 displayed a dose-
dependent inhibitory effect on biofilm formation of P. aeruginosa
FRD1 and S. aureus RN6390 (Figure 3). In the presence of 100 mg/
ml A101, about 75% of biofilm formation of P. aeruginosa FRD1
was inhibited (Figure 3A), and S. aureus RN6390 revealed .90%
inhibition (Figure 3B).
To investigate whether the inhibitory effect of A101 on bacterial
biofilm formation might due to the direct growth inhibition,
growth curve analysis was performed. The results revealed that
both P. aeruginosa FRD1 (Figure 4A) and S. aureus RN6390
(Figure 4B) grew a bit faster in the presence of 100 mg/ml A101,
indicating that A101 was not bactericidal.
The inhibitory activity of A101 on biofilm formation
occurs among multiple strains
To determine the spectrum of A101 antibiofilm activity, the
effects of A101 on biofilm formation of various strains (P. aeruginosa,
E. coli, Actinobacillus actinomycetemcomitans, S. aureus, S. epidermidis,
Enterococcus faecalis) were tested using the microtiter plate assay. As
indicated in Figure 5, biofilms formation by 12 out of 15 Gram-
negative strains (80%) and 7 out of 10 Gram-positive strains (70%)
can be inhibited by A101 under static condition, although 4
tested strains’ biofilm formation was stimulated (P. aeruginosa
ATCC27853 and CS1, S. aureus Col and E. faecalis OG1RF).
Furthermore, A101 exhibited prominent prevention effects
($50%) on 12 out of 25 tested strains (48%). These data
demonstrated the antibiofilm activity of A101 occurred across
multiple strains of Gram-negative and Gram-positive bacteria.
Although the polystyrene microtiter plate assay is a simple means
oftestingbacterialbiofilmformation,itmeasuresbiofilmformationin
static cultures but not in a naturally hydrodynamic environment. To
better demonstrate the effect of A101 on bacterial biofilm formation,
we used a flow cell model that allows the continuous flow of fresh
Figure 2. Effect of Proteinase K, Nuclease and NaIO4 on the
activity of A101. Crude-A101 (150 mg/ml) was respectively treated
with proteinase K (1 mg/ml) (A), DNaseI (100 mg/ml) + RNaseA (25 mg/
ml) (B) or NaIO4 (20 mM) (C) at 37uC for 12 h, then taken to measure the
antibiofilm activity. The strain used in this experiment was P. aeruginosa
FRD1. Error bars represent SD of three independent experiments. ‘‘Cr-
A101’’: Crude-A101.
doi:10.1371/journal.pone.0018514.g002
Figure 3. A101 inhibits bacterial biofilm formation in a
concentration dependent manner. Biofilms of P. aeruginosa FRD1
(A) and S. aureus RN6390 (B) were grown in 96-well microplates
containing medium at 37uC for 24 h. Medium was mixed with A101 of
different concentrations in a does-dependent manner. Results are the
average of six replicates 6 SD.
doi:10.1371/journal.pone.0018514.g003
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aureus RN6390 were grown in flow cell in the absence or continued
presence of A101, and biofilm was subsequently analyzed using
confocal laser scanning microscopy (CLSM). The results showed that
A101 treatment dramatically reduced biofilm development of both
strains (Figure 6A and 6B). Analysis using COMSTAT software
showed that in the presence of 100 mg/ml A101, the total surface-
bound biomass of P. aeruginosa FRD1 dropped to less than 5% of that
grown in the absence of A101 (Figure 6C Left), while the same
treatment resulted in a more than 99% decrease to the surface-bound
biomass of S. aureus RN6390 (Figure 6C Right). These findings
demonstrated that A101 also had biofilm inhibitory activity in flow
cell with dynamic medium that is similar to the models in vivo.
A101 disrupts the established bacterial biofilm
While A101 exhibited an inhibitory activity against bacterial
biofilm formation, it was of interest to explore whether the
established biofilms were also sensitive to A101. This assay was
performed by culturing the strains in flow-cell model and irrigated
with medium in absence of A101 to allow the establishment of
mature bacterial biofilms. Subsequently, the bacterial biofilms
were shifted to medium supplemented with A101, and the fate of
the bacterial biofilms was followed by CLSM. The results showed
that the pre-existing biofilms of P. aeruginosa FRD1 were disrupted
severely when treated with 100 mg/ml A101 (Figure 7A Right).
Analysis using COMSTAT software suggested that about 85% of
mature biofilms were disappeared (Figure 7C Left). Strangely,
A101 couldn’t eliminate the mature biofilms of S. aureus RN6390
at all (Figure 7B, Figure 7C Right).
A101 increases the antibiotics’ capability of killing
P. aeruginosa FRD1 biofilm
A marker signifying bacterial biofilm production in pathogens is
the development of resistance to antibiotics [3,27]. To investigate
whether A101-mediated biofilm disruption increased the antibiotic
sensitivity of bacterial biofilm, the effect of A101 on MBEC of
antibiotic was examined. P. aeruginosa FRD1 biofilm, similar to
previous reports, even at the highest concentration tested
(2048 mg/ml) were not killed by amikacin. However, the viability
of P. aeruginosa FRD1 biofilm displayed a different antibiotic
response in the presence of A101 (100 mg/ml) that addition of
amikacin (128 mg/ml) resulted in complete killing of the biofilm
(Table 1). Moreover, no synergy was detected between A101 and
the used antibiotic on planktonic P. aeruginosa FRD1, because
minimal inhibitory concentration (MIC) and minimal bactericidal
concentration (MBC) tests of amikacin resulted in the same value
in the presence and absence of A101 (data not shown). These
results suggested that A101-mediated biofilm dispersion increased
the antibiotic’s capability of killing bacterial biofilms by indirectly
targeting to bacterial cells.
A101 inhibits cell-surface adherence and intercellular
adhesion
It is well established that cell-surface interactions are critical for
bacterial biofilm formation. To investigate the effects of A101 on
the cell surface interactions, the primary adherence to abiotic
surfaces assay was performed. The initial attachment of P.
aeruginosa FRD1 to surface displayed no difference in the presence
(100 mg/ml) and absence of A101 (Figure 8A Up), whereas
significant decreases in the adhesion of S. aureus RN6390 were
observed when 100 mg/ml A101 was present (Figure 8A Down).
This demonstrated that A101 inhibiting celll-surface interactions
occurred on S. aureus RN6390, but not on P. aeruginosa FRD1.
Generally, cell-cell interactions also significantly contribute to
bacterial biofilm formation. P. aeruginosa FRD1 and S. aureus
RN6390 often grow in an aggregated state in cultures, forming
readily observable clumps (the planktonic biofilm) [28] (Figure 8B
Left). However, when A101 was present in medium, the
aggregates of P. aeruginosa FRD1 and S. aureus RN6390 were
powerfully decreased (Figure 8B Right), suggesting that A101 was
able to interfere with the cell-cell interactions and inhibit
multicellular aggregates formation of the both strains. And to
further observe the effects of A101 on the preformed aggregates,
A101 was added to the overnight cultures of strains and incubated
for 3 hours. The results showed that the percentage of P. aeruginosa
FRD1 but not S. aureus RN6390 in the cultures that were present
in aggregates were decreased by A101 (data not shown).
Discussion
To our knowledge, the biodiversity of the marine environment
and the associated chemical diversity constitute a practically
unlimited resource of new bioactive substances [29], and marine
diversity is also a potent source of identifying novel antibiofilm
compound(s) [30]. In this study, the marine bacterium Vibrio sp.
QY101 was found to secret an antibiofilm exopolysaccharide
A101.
Figure 4. Growth curve of planktonic bacteria in the presence
or absence of A101. P. aeruginosa FRD1 (A) and S. aureus RN6390 (B)
were incubated in fresh medium with or without (Control) 100 mg/ml
A101 at 37uC for 24 h with shaking. At regular intervals, 200 ml cultures
were taken to measure the absorbance at OD600 nm. Graph show the
mean of three experiments; error bars show SD.
doi:10.1371/journal.pone.0018514.g004
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proposed one of the most potential strategies for increasing the
sensitivity of pathogens in biofilm to antibiotics and host immune
systems [31], such as enzymes dissolving the matrix polymers of
the biofilm [13,32], chemical reactions blocking biofilm matrix
synthesis, and analogues of microbial signaling molecules inter-
fering with cell-to-cell communication, required for normal biofilm
formation [33,34]. Here, A101 was demonstrated to powerfully
disrupt the multicellular aggregates and established biofilm of P.
aeruginosa FRD1, and significantly increased the aminoglycosides
antibiotics’ capability of killing P. aeruginosa FRD1 biofilm. As P.
aeruginosa could cause acute and chronic lung infections and result
in significant morbidity and mortality in cystic fibrosis [35], the
effectiveness of A101 in inhibiting biofilm growth in a majority of
P. aeruginosa strains suggest that A101 might be a powerful
therapeutic tool in the treatment of P. aeruginosa infections. That
biofilm formation of few tested strains was not inhibited by A101
may be related with the complex and probably multifactorial
mechanisms involving in biofilms formation [36,37]. And similar
observation has been reported that P. aeruginosa (mainly extracel-
lular polysaccharides) exhibited different effects on biofilm
formation of different S. epidermidis strains [23,38]. In addition,
the exopolysaccharide A101 displayed inhibitory activity towards
biofilm formation of many Gram-negative and Gram-positive
bacteria, including clinic isolates. A101 is potentially superior to
other antibiofilm substances in a multispecies biofilm context.
Based on our findings, the antibiofilm activity of A101 is
independent of decreasing bacterial viability. Instead, A101
promoted the bacterial growth a little. However, further
investigation indicated that strains did not have the ability to
utilize the polysaccharide A101 as carbon source, because strains
were not able to grow in medium with A101 as the only carbon
source (data not shown). And the mechanisms about the A101
promotion bacterial growth are needed to further investigate.
Bacterial extracellular polysaccharides synthesized and secreted
by a wide range of bacteria from various environmental habitats
are complex and diverse. Some have been proved to involve the
pathogenicity [39,40], while some were found to serve a structural
role benefitting the bacterium by providing protection from
antimicrobial agents and host defenses [16,41–43], helping
nutrient acquisition [44], or promoting adherence to surfaces
[45–47] and biofilm formation [17,48]. A101 and other few
bacterial EPSs were found to negatively regulate biofilm formation
[20–23]. As it is known, polysaccharides functions are based on
their divergent compositions, biochemical characteristics and
structures [20,49]. Previous studies showed that EPSs in V. cholerae
are one important component of its biofilm [50,51], which
primarily contain neutral sugars glucose and galactose [52]. While
E. coli II CPS [53] and V. vulnificus CPS [54] with antibiofilm
activity were indicative of highly anionic nature. And A101 also
displayed high content of uronic acid sugars and electronegative,
although its monosaccharides compositions exhibited complexity.
Figure 5. Effect of A101 on Gram-negative and Gram-positive bacteria biofilm formation. Biofilms of Gram-negative (A) and Gram-
positive (B) bacteria formed in 96-well containing fresh medium with or without (Control) 100 mg/ml A101 at 37uC for 24 h. Levels of crystal violet
retained were measured spectrophotometrically (OD590). Results are the average of six replicates 6 SD at least three independent experiments. ‘‘*’’,
P,0.05; ‘‘**’’, P,0.01; ‘‘***’’, P,0.001.
doi:10.1371/journal.pone.0018514.g005
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A101 may play the crucial role for antibiofilm activities.
Cell-surfaces and cell-cell interactions play an important role in
bacterial biofilm formation [55]. Many active compounds secreted
by bacteria were reported to mediate the interaction (adhesion and
deadhesion) between microorganisms and interfaces [49]. And
receptor polysaccharides recognized by a complementary protein
adhesin were reported to mediate the establishment of productive
cell-to-surface and cell-to-cell contacts [56–58]. Recent reports
demonstrated that polysaccharide-probes have the potential to
interfere with adherence and biofilm formation [59]. The E. coli
group II CPS was also reported to inhibit biofilm formation not
only by weakening cell-surface contacts but also by reducing cell–
cell interactions [22]. In this study, A101 was indicated to inhibit
or disrupt the interactions of cell-surfaces and cell-cell. It is thus
likely that A101-mediated inhibition or disruption cell-surface and
cell-cell interactions induced the antibiofilm effects. Moreover, we
found that the complete hydrolysis of A101 lost the antibiofilm
activity. It is proposed that A101 may contain the motif recognized
by adhesins, which caused competitively blocking the recognition
of adhesins and receptor polysaccharides on strains surfaces and
interfering with the adherence of cell-surface and cell-cell.
However, investigation the possible binding of A101 with adhesins
would be needed to further understand the mechanism underlying
the antibiofilm effects.
A101 was suggested here to inhibit the cells aggregates
formation of both S. aureus RN6390 and P. aeruginosa FRD1, but
only disrupt the mature biofilm of P. aeruginosa FRD1. And further
investigation demonstrated that A101 was only able to disrupt the
formed cells aggregates of P. aeruginosa FRD1, but not that of S.
aureus RN6390 (data not shown). It has been reported that binding
of phage 1P to R. leguminosarum bv. Trifolii involved a reversible
binding to EPS and an irreversible binding to the specific
lipopolysaccharides receptors [60,61]. We proposed that the
antibiofilm activity of A101 may be involved irreversible binding
or adsorption in S. aureus RN6390, and reversible in P. aeruginosa
FRD1. Moreover, previous findings that the three-dimensional
structure and matrix composition of biofilm were physical barriers
to the penetration of antimicrobial agents [3], led us to hypothesis
that the different activity against established biofilms of the two
strains could also be related with the different architecture and
matrix composition of both biofilms: A101 maybe easily penetrate
in P. aeruginosa biofilms, but not penetrate in S. aureus biofilms.
To conclude, our findings suggest that A101 is of significance in
controlling biofilm-associated infections, even in a multispecies
biofilm context, and the antibiofilm activity appears to represent a
new function of bacterial EPSs. However, the antibiofilm activity
of A101 warrants further investigations of the structure–activity
relationships of A101 and the mechanism underlying the
antibiofilm effects.
Figure 6. Prevention biofilm formation with A101 in flow cell. Flow cells irrigated by medium with and without (Control) 100 mg/ml A101
were inoculated with P. aeruginosa FRD1 at 25uC for 2 days (A) or S. aureus RN6390 at 37uC for 24 h (B). Images and structures of biofilms in flow cells
were detected by CLSM. CLSM images are representative of three separate experiments. Biomass of biofilm in flow cells were analyzed using
COMSTAT software (C). (P,0.001).
doi:10.1371/journal.pone.0018514.g006
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Strains and growth conditions
All strains and plasmids used in this study were listed in Table 2. P.
aeruginosa was cultured in M9 medium; S. aureus, S. epidermidis, E.
faecalis,a n dA. actinomycetemcomitans were grown in Tryptone Soya
Broth (TSB) (Sigma) supplemented with 0.25% glucose; and E. coli
was cultured in Luria-Bertani (LB) medium (Sigma). The marine
bacterium Vibrio sp. QY101 was cultured in alginate medium (AM)
(w/v,3%NaCl,0.5%sodiumalginate(Sigma),0.3%KH2PO4,0.7%
K2HPO4,0 . 2 %( N H 4)2SO4, 0.01% MgSO4, 0.01% FeSO4)a t2 5 uC
to prepare A101. All the reagents used here are analytical grade.
Plasmids pMRP9-1-GFP (carbenicillin 200 mg/ml) [62] and
pSB2019-GFP (chloromycetin 15 mg/ml) [63] were transformed into
appropriate strains by electroporation for biofilm formation experi-
ments in flow cell. The software COMSTAT 7.0 was a kind gift from
Dr. Arne Heydorn and used to analyze the biofilm parameters [64,65].
Isolation and purification of A101
Polysaccharides preparation was carried out as previously
described [66,67]. Vibrio sp. QY101 cells were grown in AM with
shaking at 25uC for 4 days. The culture supernatant was
concentrated under reduced pressure at 40uC, and the EPS was
precipitated byaddingthreefoldofthevolume of95%(v/v)ethanol.
After keeping at 4uC overnight, the precipitate was dried in a Speed
Vac concentrator and dissolved in distilled water followed by
dialysis through a 14,000-molecular-weight cutoff membrane. The
retained fraction was recovered, concentrated under reduced
pressure. After removing proteins by Sevage method, it was
lyophilized to obtain the crude polysaccharide. The solution of
crude polysaccharide was applied to a DEAE Sepharose Fast Flow
column (2.6650 cm) (Pharmacia) and was eluted by a step gradient
Figure 7. Disruption of the established biofilm with A101 in flow cell. Biofilm of P. aeruginosa FRD1 in flow cells was preformed at 25uC for 2
days (A) and S. aureus RN6390 at 37uC for 24 h (B). Then mediums were switched to fresh ones with or without (Control) 100 mg/ml A101 for an
additional 12 hours. Images and structures of biofilms in flow cell were detected by CLSM. CLSM images are representative of three separate
experiments. Biomass of biofilm in flow cells were analyzed using COMSTAT software (C). (P,0.001).
doi:10.1371/journal.pone.0018514.g007
Table 1. Antibiotic sensitivity of P. aeruginosa FRD1 as a
planktonic population (MIC and MBC) and as a biofilm
population (MBEC).
Antibiotics
MIC
(mg/ml)
MBC
(mg/ml) MBEC (mg/ml)
Control
a A101 (100 mg/ml)
Amikacin 16 32 .2048 128
Tobramycin 4 8 512 16
Gentamicin 16 32 2048 64
aThe equal volume of sterile water was as control.
Results shown are representative of six replicates at least three independent
experiments.
doi:10.1371/journal.pone.0018514.t001
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sugar content of the elution was determined by the phenol-sulfuric
acid method. The fractions eluted by 0.5 mol/L NaCl were pooled,
desalted and loaded on a Sephacryl S-400 HR column
(2.66100 cm) (Pharmacia) equilibrated with 0.2 mol/L ammonium
bicarbonate. The elution was done with the same solution at a flow
rate of 12 ml/h, and the active polysaccharide fractions were
concentrated under reduced pressure named as A101.
Analysis of the infrared spectra and chemical
composition of A101
For IR spectroscopy, as previously described [68], A101 was
mixed with KBr powder, ground and then pressed into a 1 mm
pellets for FT-IR measurement in the frequency range of 4000–
500 cm
21. FT-IR spectra of A101 was measured on a Nicolet
Nexus 470 spectrometer.
Total sugar content was determined by the phenol–sulfuric acid
method using glucose as the standard [69]. Protein content was
measured by the method of BCA. The molecular weight were
assessed by HPGPC [68]. The monosaccharide components were
determined by HPLC[68]. The standard saccharides used here
were glucose, galactose, mannose, rhamnose, xylose, fucose,
arabinose, glucuronic acid, galacturonic acid and glucosamine.
Biofilm assay
Static biofilm formation assay was carried out in 96-well
microtiter plates (Costar, Cambridge, MA, USA) or mircrotiter
tubes as previously described [70,71]. Briefly, overnight cultures
were diluted to about 1610
6 cfu/ml with fresh sterile medium,
and each well of microtiter plates was filled with 100 ml aliquots of
the diluted cultures. The plates were incubated at 37uC for 24 h
without shaking for biofilm growth, and non-adherent bacteria
were washed by 0.9% (w/v) NaCl for three times. Biofilm was
strained by 0.1% (w/v) crystal violet solution for 10 min, washed
and then dissolved with 33% (v/v) acetic acid for 10 min. Biofilm
mass was determined by measuring the absorbance at 590 nm
using a microtiter plate reader (Tecan, Milan, Italy).
Dynamic biofilm formation analysis was carried out using a
‘‘once-through’’ flow cell (4.5 mm62m m 635 mm) model
[70,72]. Each cell was injected with 0.8 ml of the diluted culture
of the tested strain, and incubated for 40 min without flow. Non-
adherent bacteria were then flushed from the flow cell by adjusting
the pump to a flow rate (4 ml/h for P. aeruginosa [70], 21 ml/h for
S. aureus [72]). CLSM was performed as previously described [73].
The images were constructed with the LSM 5 image browser.
Antibiotics susceptibility assay of bacteria and biofilm
MIC, MBC and MBEC were performed as previously described
[74]. MICs of antibiotics were determined using the broth
microdilution method. Briefly, the test antibiotic was diluted with
MHB medium (Sigma) from 1024 mg/ml to 2 mg/ml by 2-fold
serial dilutions. The final concentration of bacterial cultures was
about 10
5 cfu/ml. After incubation at 37uC for 24 h, the
absorbance at 600 nm was measured using a microplate reader
to assess the cell growth. To assay the MBC, 100 ml cultures was
taken from each well in the above MIC experiment, centrifuged
and washed three times with PBS and plated on a LB agar plate
separately, and bacterial cells were enumerated after incubation at
37uC for 24 h. MBEC
TM (MBEC Bio-Products, Edmonton,
Canada) assays were performed here to detect tolerance to
antibiotics of biofilm bacteria. The device used here is a platform
carrying 96 polystyrene pegs that fit in a microtiter plate. For
biofilm formation, the device was placed in a tray filled with MHB
and cells (,10
7 cfu/ml) and was incubated on a tilting shaker,
which provides a shearing force, at 37uC for 22 h. After biofilms
formed on the pegs, non-adherent bacteria on the pegs were
washed from the pegs in a 96-well microtiter plate containing
sterile 0.9% (w/v) NaCl. Pegs with the bacterial biofilm were
placed into a new microtiter plate with fresh medium and
incubated at 37uC for 24 h with antibiotic, which was diluted from
1024 mg/ml to 2 mg/ml. The remaining biofilm was transferred
from the pegs into a second 96-well microtiter plate containing
fresh broth medium by being sonicated for 5 min in a water bath
sonicator. This plate was incubated at 37uC for 24 h. Growth of
bacteria in a particular well indicates regrowth of planktonic
bacteria from surviving biofilm.
Figure 8. Inhibition of A101 on the early adherence to surfaces
and cell aggregates of strains. (A) Detection the numbers of P.
earuginosa FRD1 (Up) or S. aureus RN6390 (Down) attached on the
surfaces with (Right) or without (Left) (Control) 100 mg/ml A101. The
numbers of adherent cells to the surfaces were detected by phase-
contrast microscopy6600. (B) Observation the formation of aggregates
for P. earuginosa FRD1 (Up) or S. aureus RN6390 (Down) in cultures with
(Right) or without (Left) (Control) 100 mg/ml A101. Strains were
cultivated in medium (M9 (FRD1) or 20% TSB+0.25% glucose
(RN6390)) with or without A101 at 37uC for 24 h with shaking, and
then observed. The numbers of cells aggregates in cultures were
detected by phase-contrast microscopy 6200.
doi:10.1371/journal.pone.0018514.g008
Antibiofilm Activity of a Bacterial Polysaccharide
PLoS ONE | www.plosone.org 8 April 2011 | Volume 6 | Issue 4 | e18514Early bacterial adhesion assay
Early adherence to a polystyrene surface was analyzed as
previously described [75] with the following modifications.
Overnight cultures of tested strains were grown in medium
supplemented with or without A101 at 37uC for 12 h, then adjusted
with fresh sterile medium with or without A101 to an optical density
at 600 nm of 0.1. Each suspension was added to 24-well microtiter
plates (Costar, Cambridge, MA, USA) and incubated at 37uC for
1 h. The 24-well microtiter plates were rinsed gently at least six
times with sterile phosphate buffer solution (pH 7.5) and strained by
0.1% crystal violet for 20 min. Adherent bacterial cells were
observed by phase contrast microscopy and counted. The results
represent the means of four different microscopic fields.
Supporting Information
Figure S1 Purification of the polysaccharides obtained
from marine bacterium Vibrio sp. QY101. (A) A mixture of
polysaccharides obtained from the marine bacterium Vibrio sp.
QY101 was applied to a DEAE Sepharose Fast Flow column and
eluted as described in [Method]. The fractions containing the
active polysaccharides were pooled and named as pre-A101. (B)
pre-A101 obtained on DEAE Sepharose Fast Flow was applied to
a Sephacryl S-400 HR column and eluted as described in Method.
The fractions containing the active polysaccharides were pooled
and named as A101.
(TIF)
Table S1 The monosaccharides compositions and the
average Mw of A101.
(DOC)
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Table 2. Strains and plasmids list.
Strains or plasmids Relevant characteristics Source or reference
Pseudomonas aeruginosa
FRD1 A cystic fibrosis isolate mucA22 [76]
PAO1 Prototroph, nonmucoid ATCC 15692 [77]
9027 A clinical isolate recovered from an ear infection ATCC
a
27853 A clinical isolate from blood ATCC
a
CS1-8 Clinical strains AHQU
b
Escherichia coli
25404 A wide K-12 strain of E. coli [78]
MG1655 A wild-type laboratory strain of E. coli K-12 [78]
Actinobacillus actinomycetemcomitans 43718 The smooth laboratory strain Y4 ATCC
a
Staphylococcus aureus
V329 A bovine mastitis subclinical isolate [71]
15981 A clinical isolate [71]
8325 A strain with rsbU
2, tcaR
2 [71]
RN4220 A restriction-deficient mutant of 8325-4 [71]
RN6390 A laboratory strain derived from 8325-4 [79]
Newmen A human clinical isolate [71]
Col A methicillin-resistant isolate [71]
Staphylococcus epidermidis
QY301 A clinical strain AHQU
b
RP62A A laboratory strain ATCC
a
Enterococcus feacalis OG1RF A laboratory strain [80]
Vibrio sp. QY101 A isolate from a decaying thallus of Laminaria This work
Plasmids
pMRP9-1 Car resistance [62]
pSB2019 Chl resistance [63]
aAmerican Type Culture Collection.
bAffiliated Hospital of Qingdao University.
doi:10.1371/journal.pone.0018514.t002
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